Company Profile

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE1620.3022.45 (+1.41 % )
PREV CLOSE (Rs.) 1597.85
OPEN PRICE (Rs.) 1607.00
BID PRICE (QTY) 1614.35 (4 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1204
TODAY'S LOW / HIGH (Rs.)1574.15 1621.95
52 WK LOW / HIGH (Rs.)957 1984.75
NSE1615.95 15.7 (+0.98 % )
PREV CLOSE(Rs.) 1600.25
OPEN PRICE (Rs.) 1608.30
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 48617
TODAY'S LOW / HIGH(Rs.) 1573.05 1624.00
52 WK LOW / HIGH (Rs.)956.05 1985

Financial ratio

Particulars Mar  2021 Mar  2020 Mar  2019 Mar  2018 Mar  2017
Operational & Financial Ratios          
   Earnings Per Share (Rs) 57.96 35.20 24.11 16.55 21.70
   CEPS(Rs) 66.92 43.83 31.11 23.42 27.31
   DPS(Rs) 16.50 11.00 5.00 2.00 1.00
   Book NAV/Share(Rs) 234.17 185.75 184.47 172.50 160.77
   Tax Rate(%) 24.86 21.93 32.41 28.48 19.81
Margin Ratios          
   Core EBITDA Margin(%) 27.23 21.28 18.61 14.09 16.72
   EBIT Margin(%) 29.58 19.84 17.75 13.97 17.20
   Pre Tax Margin(%) 29.22 19.66 17.47 13.72 16.80
   PAT Margin (%) 21.96 15.35 11.80 9.81 13.48
   Cash Profit Margin (%) 25.32 19.09 15.19 13.84 16.93
Performance Ratios          
   ROA(%) 19.55 12.53 8.52 6.43 8.99
   ROE(%) 27.64 18.69 13.28 9.89 14.48
   ROCE(%) 36.53 23.71 19.59 13.70 16.87
   Asset Turnover(x) 0.89 0.82 0.72 0.66 0.67
   Sales/Fixed Asset(x) 1.73 1.57 1.54 1.35 1.53
   Working Capital/Sales(x) 1.69 2.34 2.04 1.83 2.66
Efficiency Ratios          
   Fixed Capital/Sales(x) 0.58 0.64 0.65 0.74 0.65
   Receivable days 65.62 67.22 67.63 73.15 71.84
   Inventory Days 55.59 53.31 50.81 53.43 51.77
   Payable days 43.67 38.74 32.21 33.66 32.86
Valuation Parameters          
   PER(x) 21.63 14.44 14.91 18.68 15.99
   PCE(x) 18.73 11.60 11.56 13.20 12.71
   Price/Book(x) 5.35 2.74 1.95 1.79 2.16
   Yield(%) 1.32 2.16 1.39 0.65 0.29
   EV/Net Sales(x) 4.74 2.21 1.75 1.83 2.18
   EV/Core EBITDA(x) 14.40 9.17 8.28 10.15 10.54
   EV/EBIT(x) 16.04 11.15 9.86 13.08 12.66
   EV/CE(x) 3.77 1.95 1.23 1.16 1.43
   M Cap / Sales 4.74 2.21 1.76 1.83 2.15
Growth Ratio          
   Net Sales Growth(%) 15.09 8.00 16.23 3.32 11.10
   Core EBITDA Growth(%) 57.02 23.38 36.50 -9.95 7.56
   EBIT Growth(%) 71.55 20.75 47.71 -16.09 6.26
   PAT Growth(%) 64.66 40.43 39.83 -24.77 14.37
   EPS Growth(%) 64.66 45.99 45.66 -23.72 13.24
Financial Stability Ratios          
   Total Debt/Equity(x) 0.02 0.02 0.02 0.02 0.04
   Current Ratio(x) 2.76 2.47 2.03 2.05 1.74
   Quick Ratio(x) 2.25 1.94 1.72 1.76 1.45
   Interest Cover(x) 83.43 108.09 62.74 56.54 43.81
   Total Debt/Mcap(x) 0.00 0.01 0.01 0.01 0.02